Jl. Mainardi et al., SYNERGISTIC EFFECT OF AMOXICILLIN AND CEFOTAXIME AGAINST ENTEROCOCCUS-FAECALIS, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 1984-1987
The antibacterial efficacy of the combination of amoxicillin and cefot
axime was assessed against 50 clinical strains of Enterococcus faecali
s. For 48 of 50 strains, the MIC of amoxicillin that inhibited 50% of
isolates tested decreased from 0.5 mu g/ml (range, 0.25 to 1 mu g/ml)
to 0.06 mu g/ml (range, 0.01 to 0.25 mu g/ml) in the presence of only
4 mu g of cefotaxime per mi, Alternatively, the MIC of cefotaxime that
inhibited 50% of isolates tested decreased from 256 mu/ml (range, 8 t
o 512 mu g/ml) to 1 mu g/ml (range, 0.5 to 16 mu g/ml) in the presence
of only 0.06 mu g of amoxicillin per ml. For JH2-2, a reference strai
n of E. faecalis, the MICs of amoxicillin, cefotaxime, and amoxicillin
in the presence of cefotaxime (4 mu g/ml) were 0.5, 512, and 0.06 mu
g/ml, respectively, By using a penicillin-binding protein (PBP) compet
ition assay, it was shown that with cefotaxime, 50% saturation of PBPs
2 and 3 was obtained at very low concentrations (<1 mu g/ml), while 5
0% saturation of PBPs 1, 4, and 5 was obtained with greater than or eq
ual to 128 mu g/ml. With amoxicillin, 50% saturation of PBPs 4 and 5 w
as obtained at 0.12 and 0.5 mu g/ml, respectively, Therefore, the part
ial saturation of PBPs 4 and 5 by amoxicillin combined with the total
saturation of PBPs 2 and 3 by cefotaxime could be responsible for the
observed synergy between these two compounds.